CXCL13 and peeling skin syndrome: Prompted by these findings, we sought to validate the clinical utility of CXCL13 in pSS by examining its expression in paired samples of serum, saliva and MSG biopsies from patients with pSS (with or without NHL), sicca-controls, and healthy individuals.